MEI Pharma Inc (MEIP) — Cash Flow Reinvestment Rate

Latest as of December 2020: 1.27x

MEI Pharma Inc (MEIP) has a Cash Flow Reinvestment Rate of 1.27x as of December 2020, reinvesting $5.14 Million (capex $56.00K plus investments $-5.09 Million) from operating cash flow of $4.05 Million. Check earnings quality score of MEI Pharma Inc to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

1.27x
(Capex + Investments) / Operating CF

Total Reinvested

$5.14 Million
Capex + Investments

Operating Cash Flow

$4.05 Million
USD

Capital Expenditures

$56.00K
USD

MEI Pharma Inc Cash Flow Reinvestment Rate (2017–2020)

Historical reinvestment intensity for MEI Pharma Inc across 2 annual periods. Explore cash flow to debt ratio of MEI Pharma Inc to assess how comfortably operating cash covers total debt obligations.

Annual Cash Flow Reinvestment Rate for MEI Pharma Inc (2017–2020)

Year-by-year capital reinvestment analysis for MEI Pharma Inc. For live market cap and broader valuation context, see MEIP market cap overview.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2020 3.10x $106.29 Million $34.26 Million $894.00K ▲ +7.3%
2017 2.89x $10.08 Million $3.49 Million $51.00K
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow